Income statement revenue $551.68M (+0.5% YoY).Operating income $39.13M (+269.6% YoY).Pre-tax result $23.14M (-31.3% YoY).Net result $19.09M (-46.0% YoY).

Infusion Consumables: $289.28M (+5.9% YoY)
Infusion Systems: $189M (+12.7% YoY)
Vital Care: $73.41M (-32.1% YoY)
Selling, general and administrative: $151.92M (-4.7% YoY)
Research and development: $22.7M (+3.8% YoY)
Restructuring, strategic transaction and integration: $21.3M (+31.3% YoY)
Other expense: $15.98M
Income tax expense: $7.07M (+500.2% YoY)

Loading financials

Income statement income statement flow. Revenue $551.68M. Net result $19.09M.

Income statement revenue $551.68M (+0.5% YoY).Operating income $39.13M (+269.6% YoY).Pre-tax result $23.14M (-31.3% YoY).Net result $19.09M (-46.0% YoY).

Infusion Consumables: $289.28M (+5.9% YoY)
Infusion Systems: $189M (+12.7% YoY)
Vital Care: $73.41M (-32.1% YoY)
Selling, general and administrative: $151.92M (-4.7% YoY)
Research and development: $22.7M (+3.8% YoY)
Restructuring, strategic transaction and integration: $21.3M (+31.3% YoY)
Other expense: $15.98M
Income tax expense: $7.07M (+500.2% YoY)